0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Special Communication |  FREE
Aaron S. Kesselheim, MD, JD, MPH; Jerry Avorn, MD; Ameet Sarpatwari, JD, PhD
JAMA. 2016;316(8):858-871. doi:10.1001/jama.2016.11237.
Includes: CME

News From the Food and Drug Administration | 
Rebecca Voelker, MSJ
JAMA. 2016;316(7):703. doi:10.1001/jama.2016.10684.

Original Investigation | 
Dhruv S. Kazi, MD, MSc, MS; Andrew E. Moran, MD, MPH; Pamela G. Coxson, PhD; et al.
JAMA. 2016;316(7):743-753. doi:10.1001/jama.2016.11004.
Includes: CME, Supplemental Content

Capitol Health Call | 
Rita Rubin, MA
JAMA. 2016;316(6):575. doi:10.1001/jama.2016.10615.

Viewpoint | 
Humayun J. Chaudhry, DO, MS; Arthur S. Hengerer, MD; Gregory B. Snyder, MD
JAMA. 2016;316(6):577-578. doi:10.1001/jama.2016.7741.

Original Investigation | 
Suetonia C. Palmer, PhD; Dimitris Mavridis, PhD; Antonio Nicolucci, MD; et al.
JAMA. 2016;316(3):313-324. doi:10.1001/jama.2016.9400.
Includes: Supplemental Content

From the JAMA Network | 
Ameet Sarpatwari, JD, PhD; Aaron S. Kesselheim, MD, JD, MPH
JAMA. 2016;315(24):2724-2725. doi:10.1001/jama.2016.3851.
Includes: Supplemental Content

JAMA Patient Page |  FREE
Aria A. Razmaria, MD, MSc
JAMA. 2016;315(24):2746. doi:10.1001/jama.2016.3990.
Includes: Supplemental Content

News From the Food and Drug Administration | 
Rebecca Voelker, MSJ
JAMA. 2016;315(23):2514. doi:10.1001/jama.2016.7290.

News From the Food and Drug Administration | 
Rebecca Voelker, MSJ
JAMA. 2016;315(23):2514. doi:10.1001/jama.2016.7382.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Internal Medicine
Invited Commentary  | 
Medication Review After a Fracture—Absolutely Essential
Sarah D. Berry, MD, MPH; Douglas P. Kiel, MD, MPH
JAMA Internal Medicine
Original Investigation  | 
Patterns of Prescription Drug Use Before and After Fragility Fracture
Jeffrey C. Munson, MD, MSCE; Julie P. W. Bynum, MD, MPH; John-Erik Bell, MD, MS; et al.
JAMA Oncology
Original Investigation  | 
Incidence of Programmed Cell Death 1 Inhibitor–Related Pneumonitis in Patients With Advanced Cancer A Systematic Review and Meta-analysis
Mizuki Nishino, MD, MPH; Anita Giobbie-Hurder, MS; Hiroto Hatabu, MD, PhD; et al.
JAMA Oncology
Viewpoint  | 
Highlights in Genitourinary (Prostate) Cancer
Robert Dreicer, MD, MS